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Abstract 
Background: Campylobacter jejuni infections are of rising importance worldwide. Given that innate immune recep-
tors including nucleotide-oligomerization-domain-2 (Nod2) are essentially involved in combating enteropathogenic 
infections, we here surveyed the impact of Nod2 in murine campylobacteriosis.
Methods and results: In order to overcome physiological colonization resistance preventing from C. jejuni infec-
tion, we generated secondary abiotic  Nod2−/− and wildtype (WT) mice by broad-spectrum antibiotic treatment. 
Mice were then perorally infected with C. jejuni strain 81-176 on 2 consecutive days and could be stably colonized 
by the pathogen at high loads. Notably, Nod2 deficiency did not affect gastrointestinal colonization properties of C. 
jejuni. Despite high intestinal pathogenic burdens mice were virtually uncompromised and exhibited fecal blood in 
single cases only. At day 7 postinfection (p.i.) similar increases in numbers of colonic epithelial apoptotic cells could 
be observed in mice of either genotype, whereas C. jejuni infected  Nod2−/− mice displayed more distinct regenera-
tive properties in the colon than WT controls. C. jejuni infection was accompanied by increases in distinct immune 
cell populations such as T lymphocytes and regulatory T cells in mice of either genotype. Increases in T lymphocytes, 
however, were less pronounced in large intestines of  Nod2−/− mice at day 7 p.i. when compared to WT mice, whereas 
colonic numbers of B lymphocytes were elevated in WT controls only upon C. jejuni infection. At day 7 p.i., colonic 
pro-inflammatory mediators including nitric oxide, TNF, IFN-γ and IL-22 increased more distinctly in  Nod2−/− as com-
pared to WT mice, whereas C. jejuni induced IL-23p19 and IL-18 levels were lower in the large intestines of the former. 
Converse to the colon, however, ileal concentrations of nitric oxide, TNF, IFN-γ, IL-6 and IL-10 were lower in  Nod2−/− as 
compared to WT mice at day 7 p.i. Even though MUC2 was down-regulated in C. jejuni infected  Nod2−/− mice, this did 
not result in increased pathogenic translocation from the intestinal tract to extra-intestinal compartments.
Conclusion: In secondary abiotic mice, Nod2 signaling is involved in the orchestrated host immune responses upon 
C. jejuni infection, but does not control pathogen loads in the gastrointestinal tract.
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mice, Bacterial colonization properties, Pro-inflammatory cytokines, Adaptive immune cells, IL-23/IL-22/IL-18 axis, 
Apoptosis, Bacterial translocation, Mucin-2
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Background
Human Campylobacter jejuni infections have been 
progressively rising during the past decades [1–3]. A 
plethora of wild and domestic animals harbor C. jejuni 
as commensal bacteria within their intestinal microbi-
ota. Upon zoonotic transmission from livestock animals 
humans become infected via consumption of contami-
nated meat or surface water [4–6]. Infected individuals 
may be asymptomatic, present with rather mild malaise 
and watery diarrhea or with full blown disease charac-
terized by acute enterocolitis with abdominal cramps, 
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fever, and bloody, inflammatory diarrhea lasting for days 
or even weeks [1]. Whereas disease is self-limiting in the 
vast majority of cases, post-infectious sequelae affecting 
the joints (i.e. reactive arthritis), the nervous system (i.e. 
Guillain–Barré syndrome, Miller Fisher syndrome and 
Bickerstaff encephalitis) or the intestinal tract (i.e. irri-
table bowel syndrome) might arise sporadically [1, 3, 7]. 
Susceptibility to pathogenic infection is highly depending 
on the distinct intestinal microbiota composition of the 
respective host. Conventionally colonized adult mice, for 
instance, are protected from C. jejuni infection and expel 
the pathogen within a few days even upon peroral high 
dose infection [8–10]. Modification of the murine micro-
biota by broad-spectrum antibiotic treatment, however, 
compromizes physiological colonization resistance and 
facilitates stable gastrointestinal C. jejuni infection of the 
resulting secondary abiotic mice at high loads [8, 10, 11]. 
In turn, secondary abiotic mice present with distinct C. 
jejuni induced pro-inflammatory immune and colonic 
apoptotic responses thereby mimicking key features of 
human campylobacteriosis [6, 8]. Hence, the secondary 
abiotic mouse model has been proven well-suitable to 
dissect enteropathogenic-host interactions in  vivo [10, 
11].
Host immune responses are pivotal for combating 
enteropathogenic including C. jejuni infections. The 
nucleotide-binding oligomerization domain (Nod)-like 
receptors comprize an important family of signaling 
molecules sensing microbial products and damage-asso-
ciated factors and thus contributing to innate immunity 
[12]. Among these, Nod2 is expressed by innate (such as 
macrophages and dendritic cells) and adaptive immune 
cell subsets including T lymphocytes as well as by Paneth 
cells [13–15]. Upon activation by muramyl dipeptide 
(MDP), a constituent of bacterial peptidoglycans, Nod2 
confers resistance to a broad variety of bacterial species 
[12, 16–18]. To date it is still unclear, however, whether 
Nod2 can also sense other microbial molecules or 
whether it rather acts as a mere signaling partner [19]. 
The importance of Nod2 in sensing and elimination of 
enteropathogens have been demonstrated in  vivo, given 
that  Nod2−/− mice were more susceptible to Listeria 
monocytogenes or Yersinia pseudotuberculosis infection 
[20, 21].
In the present study we investigated the impact of 
Nod2 in C. jejuni infection of secondary abiotic mice. 
We addressed whether pathogenic colonization proper-
ties, potential translocation of viable bacteria to extra-
intestinal compartments, infection induced macroscopic 
and microscopic sequelae, and pro-inflammatory intesti-
nal as well as systemic immune responses were affected 




All animal experiments were conducted according to the 
European Guidelines for animal welfare (2010/63/EU) 
with approval of the commission for animal experiments 
headed by the “Landesamt für Gesundheit und Soziales” 
(LaGeSo, Berlin, registration number G0135/10). Animal 
welfare was monitored twice daily by assessment of clini-
cal conditions.
Generation of secondary abiotic mice and C. jejuni 
infection
Female Nod2 deficient  (Nod2−/−) mice (in C57BL/6j 
background) and matched wildtype mice were reared and 
maintained within the same specific pathogen free (SPF) 
unit of the Forschungseinrichtungen für Experimentelle 
Medizin (FEM, Charité-University Medicine Berlin). In 
order to overcome physiological colonization resistance 
and thus assure stable pathogenic colonization of the 
gastrointestinal tract [8], secondary abiotic (i.e. gnotobi-
otic) mice virtually lacking an intestinal microbiota were 
generated upon broad-spectrum antibiotic treatment for 
at least 8  weeks as described earlier [8, 22]. Three days 
before infection, the antibiotic cocktail was replaced 
by sterile water. Mice were then perorally infected with 
 109 colony forming units (CFU) of viable C. jejuni strain 
81-176 in a volume of 0.3 mL phosphate buffered saline 
(PBS; Gibco, life technologies, UK) on two consecutive 
days (days 0 and 1) by gavage as described previously [8]. 
To prevent mice from contaminations, animals were con-
tinuously kept in a sterile environment (autoclaved food 
and drinking water or sterile antibiotic cocktail) and han-
dled under strict aseptic conditions.
Clinical conditions
To assess clinical signs of C. jejuni induced infection a 
standardized cumulative clinical score (maximum 12 
points), addressing the occurrence of blood in feces (0: no 
blood; 2: microscopic detection of blood by the Guajac 
method using Haemoccult, Beckman Coulter/PCD, Ger-
many; 4: macroscopic blood visible), diarrhea (0: formed 
feces; 2: pasty feces; 4: liquid feces), and the clinical 
aspect (0: normal; 2: ruffled fur, less locomotion; 4: isola-
tion, severely compromized locomotion, pre-final aspect) 
was used on a daily basis as described earlier [23–25].
Sampling procedures and histopathology
Mice were sacrificed at day 7 postinfection (p.i.) by 
isoflurane treatment (Abbott, Greifswald, Germany). 
Intestinal ex  vivo biopsies were asserved under ster-
ile conditions and collected from each mouse in paral-
lel for microbiological, immunohistopathological and 
immunological analyses. Histopathological changes 
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were determined in samples derived from the colon that 
were immediately fixed in 5% formalin and embedded 
in paraffin. Sections  (5 μm) were stained with hema-
toxylin and eosin (H&E), examined by light microscopy 
(magnification  ×100 and ×400) and histopathological 
changes quantitatively assessed applying a standardized 
histopathological scoring system (maximum 4 points) as 
described previously [26].
Immunohistochemistry
In situ immunohistochemical analysis of colonic paraf-
fin sections was performed as stated elsewhere [24, 25, 
27, 28]. Primary antibodies against cleaved caspase-3 
(Asp175, Cell Signaling, USA, 1:200), Ki67 (TEC3; Dako, 
Denmark; 1:100), CD3 (#N1580; Dako; 1:10), FOXP3 
(FJK-16s; eBioscience, Germany; 1:100) and B220 (eBio-
science; 1:200) were used. For each animal, the aver-
age number of positively stained cells within at least six 
high power fields (HPF, 0.287  mm2, ×400 magnifica-
tion) were determined lightmicroscopically by a blinded 
investigator.
Quantitative analysis of bacterial colonization
Viable C. jejuni were quantitatively assessed in feces over 
time p.i. or at time of necropsy (i.e. day 7 p.i.) in luminal 
samples taken from the gastrointestinal tract (i.e. stom-
ach, duodenum, ileum and colon) and in homogenates 
of ex  vivo biosies taken from mesenteric lymph nodes 
(MLN), spleen, liver and kidney, dissolved in sterile PBS 
and serial dilutions streaked onto Karmali- and Colum-
bia-Agar supplemented with 5% sheep blood (Oxoid) for 
two days at 37  °C under microaerobic conditions using 
CampyGen gas packs (Oxoid). The respective weights of 
fecal or tissue samples were determined by the difference 
of the sample weights before and after asservation. The 
detection limit of viable pathogens was ≈100 CFU per g.
Cytokine detection in supernatants of intestinal 
and extra‑intestinal ex vivo biopsies
Colonic and ileal ex vivo biopsies were cut longitudinally 
and washed in PBS. MLN, spleen or strips of approxi-
mately 1  cm2 respective intestinal tissues were placed 
in 24-flat-bottom well culture plates (Nunc, Wiesbaden, 
Germany) containing 500  μL serum-free RPMI 1640 
medium (Gibco, life technologies, Paisley, UK) supple-
mented with penicillin (100 U/mL) and streptomycin 
(100 µg/mL; PAA Laboratories). After 18 h at 37 °C, cul-
ture supernatants were tested for TNF, IFN-γ, MCP-1, 
IL-12p70, IL-6 and IL-10 by the Mouse Inflammation 
Cytometric Bead Assay (CBA; BD Biosciences, Heidel-
berg, Germany) on a BD FACSCanto II flow cytometer 
(BD Biosciences). Nitric oxide (NO) was measured by 
Griess reaction as described earlier [22].
Real‑time PCR
RNA was isolated from snap frozen colonic ex vivo biop-
sies, reverse transcribed and analyzed as described pre-
viously [29]. Murine mucin-2 (MUC2), IL-23p19, IL-22, 
and IL-18 mRNA expression was analyzed using Light 
Cycler Data Analysis Software (Roche). The mRNA of 
the housekeeping gene for hypoxanthine-phosphori-
bosyltransferase (HPRT) was used as reference, and the 
mRNA expression levels of the individual genes were 
normalized to the lowest measured value and expressed 
as fold expression (Arbitrary Units).
Statistical analysis
Medians, means and levels of significance were deter-
mined using Mann–Whitney test (GraphPad Prism v5, 
La Jolla, CA, USA) as indicated. Two-sided probability 
(p) values ≤0.05 were considered significant.
Results
Campylobacter jejuni colonization alongside the 
gastrointestinal tract and clinical conditions in secondary 
abiotic  Nod2−/− mice
Given that the intestinal microbiota prevents the murine 
host from stable C. jejuni infection [8, 10], we gener-
ated secondary abiotic  Nod2−/− mice and WT counter-
parts by broad-spectrum antibiotic treatment in order 
to overcome physiological colonization resistance. Fol-
lowing peroral infection with  109 viable bacteria of C. 
jejuni strain 81-176 on 2 consecutive days (i.e. days 0 and 
1) by gavage, the pathogen could stably establish within 
the gastrointestinal tract with highest loads of approxi-
mately  109 CFU per g in the colon at day 7 p.i. (Fig. 1a, b). 
Nod2 did not impact colonization properties in a biologi-
cally relevant fashion as indicated by similar intestinal C. 
jejuni loads in infected  Nod2−/− and WT mice (Fig. 1a, 
b). Fecal C. jejuni counts were slightly lower (approxi-
mately one order of magnitude) in  Nod2−/− as compared 
to WT mice at day 4 p.i. (p  <  0.05; Fig.  1a), whereas at 
necropsy, duodenal pathogenic burdens were even mar-
ginally higher (approximately 0.5 log) in the former 
(p < 0.05; Fig. 1b).
We further surveyed whether Nod2 deficiency had 
an impact on clinical conditions upon murine C. jejuni 
infection. To address this, we applied a cumulative clini-
cal score assessing gross clinical aspects of mice, fecal 
consistency and abundance of blood in stool samples. 
Overall, mice of either genotype were virtually uncom-
promised upon C. jejuni infection (Fig.  1c). As early as 
5  days p.i., 23.9 and 10.5% of WT and  Nod2−/− mice, 
respectively, displayed bloody stool microscopically or 
even macroscopically, whereas respective fecal blood 
positivity rates were 8.7 and 10.5% at day 7 p.i. (Addi-
tional file 1: Figure S1).
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Microscopic inflammatory changes in large intestines of C. 
jejuni infected secondary abiotic  Nod2−/− mice
We next determined potential Nod2 dependent histo-
pathological sequelae of C. jejuni infection in colonic 
paraffin sections applying a standardized histopatho-
logical scoring system. Slightly higher histopathologi-
cal scores could be assessed in the large intestines of C. 
jejuni infected as compared to naive WT mice indicative 
for single isolated to mild scattered cell infiltrates within 
the mucosa (p  <  0.001; Fig.  2a; Additional file  2: Figure 
S2). In  Nod2−/− mice a trend towards C. jejuni induced 
increases in colonic histopathological scores could be 
observed at day 7 p.i. (n.s. versus naive; Fig.  2a; Addi-
tional file  2: Figure S2). Since apoptosis constitutes an 
established marker for the microscopic evaluation of 
intestinal inflammation in murine campylobacteriosis 
[8], we stained colonic paraffin sections with caspase-3 
antibodies. As compared to naive counterparts, colonic 
epithelial apoptotic cell numbers increased more than 
threefold until day 7 following C. jejuni infection of 
 Nod2−/− and WT mice (p < 0.005 and p < 0.001, respec-
tively; Fig.  2b; Additional file  3: Figure S3). Increases in 
apoptotic cell numbers were accompanied by elevated 
colonic epithelial Ki67 positive cell counts at day 7 p.i. 
(p < 0.001 vs naive; Fig. 2c; Additional file 4: Figure S4), 
indicative for proliferative/regenerative measures coun-
teracting potential cell damage. Notably, Ki67 positive 
cell numbers were higher in infected  Nod2−/− as com-
pared to WT mice (p  <  0.001; Fig. 2c; Additional file  4: 
Figure S4). Hence, comparable clinical sequelae of C. 
jejuni infection of  Nod2−/− and WT mice were paralleled 
by similar microscopic inflammatory changes within 
the infected large intestines, whereas C. jejuni infected 
 Nod2−/− mice exhibited more distinct regenerative prop-
erties in the colon than WT controls.
Colonic immune cell responses in C. jejuni infected 
secondary abiotic  Nod2−/− mice
Given that recruitment of immune cells to the site of 
infection is a hallmark of intestinal inflammation in 
murine C. jejuni infection models [8], we next quanti-
tatively assessed distinct immune cell populations in 
colonic paraffin sections applying in  situ immunohis-
tochemistry. Until day 7 p.i., colonic T lymphocytes 
increased more than threefold in WT control animals, 
but less distinctly in  Nod2−/− mice (p  <  0.001; Fig.  3a; 
Additional file  5: Figure S5). Whereas mice of either 
genotype displayed elevated Treg numbers in their large 
intestines at day 7 p.i. (p < 0.001 vs naive; Fig. 3b; Addi-
tional file  6: Figure S6), B lymphocytes increased in C. 
jejuni infected WT mice only (p  <  0.001; Fig.  3c; Addi-
tional file  7: Figure S7). Interestingly, naive secondary 
Fig. 1 Gastrointestinal colonization densities and clinical conditions 
in C. jejuni infected secondary abiotic mice  Nod2−/− mice. Second-
ary wildtype (WT; white circles) and  Nod2−/− mice (black circles) were 
generated by broad-spectrum antibiotic treatment and perorally 
infected with C. jejuni strain 81-176 by gavage at day (d) 0 and d1. 
Pathogenic loads (CFU, colony forming units per gram) were assessed 
in a fecal samples over time postinfection as indicated and in b 
defined parts of the gastrointestinal tract at d7 p.i. by culture. Num-
bers of mice harboring C. jejuni out of the total number of analyzed 
animals are given in parentheses. c Clinical symptoms were assessed 
before and after infection applying a standardized clinical scoring 
system (see “Methods”). Medians (black bars), numbers of mice (in 
parentheses) and levels of significance (p-values) determined by 
Mann–Whitney U test are indicated. Data were pooled from at least 
three independent experiments
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abiotic  Nod2−/− mice exhibited higher B cell counts as 
compared to WT counterparts (p  <  0.05; Fig.  3c; Addi-
tional file 7: Figure S7) that did not further increase upon 
C. jejuni infection of the former (n.s.; Fig.  3c). Hence, 
 Nod2−/− mice displayed less pronounced C. jejuni 
induced increases in T lymphocytes.
Colonic cytokine secretion in C. jejuni infected secondary 
abiotic mice lacking Nod2
We next surveyed C. jejuni induced pro-inflammatory 
cytokine secretion in colonic ex  vivo biopsies. At day 7 
p.i., pro-inflammatory mediators such as nitric oxide, 
TNF, IFN-γ, MCP-1 and IL-6 were elevated in large 
Fig. 2 Microscopic large intestinal changes in C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT; white circles) 
and  Nod2−/− mice (black circles) were generated by broad-spectrum antibiotic treatment and perorally infected with C. jejuni strain 81-176 by 
gavage at day (d) 0 and d1. a Histopathological mucosal changes were assessed in H&E stained large intestinal paraffin sections. Furthermore, the 
average number of colonic epithelial b apoptotic cells (positive for caspase-3, Casp3) and c proliferating cells (positive for Ki67) from six high power 
fields (HPF, ×400 magnification) per animal was determined microscopically in immunohistochemically stained colonic paraffin sections at day 7 
following C. jejuni infection. Naive (N) secondary abiotic mice served as uninfected controls. Medians (black bars), levels of significance (p-values) 
determined by Mann–Whitney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent 
experiments
Fig. 3 Large intestinal immune cell populations in C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT; white circles) 
and  Nod2−/− mice (black circles) were generated by broad-spectrum antibiotic treatment and perorally infected with C. jejuni strain 81-176 by gav-
age at day (d) 0 and d1. The average number of colonic epithelial a T lymphocytes (positive for CD3), b regulatory T cells (Treg; positive for FOXP3) 
and c B lymphocytes (positive for B220) from six high power fields (HPF, ×400 magnification) per animal was determined microscopically in immu-
nohistochemically stained colonic paraffin sections at day 7 following C. jejuni infection. Naive (N) secondary abiotic mice served as uninfected 
controls. Medians (black bars), levels of significance (p-values) determined by Mann–Whitney U test and numbers of analyzed animals (in parenthe-
ses) are indicated. Data were pooled from four independent experiments
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intestines of both  Nod2−/− and WT mice (p < 0.05–0.001; 
Fig. 4a–e). C. jejuni induced increases in nitric oxide, TNF 
and IFN-γ were, however, more pronounced in  Nod2−/− 
mice as compared to WT counterparts (p  <  0.05–0.005; 
Fig.  4a–c). Notably, C. jejuni infection resulted not only 
in enhanced pro-inflammatory, but also increased anti-
inflammatory cytokine responses as indicated by elevated 
IL-10 levels in colonic ex vivo biopsies derived from both 
 Nod2−/− and WT mice at day 7 p.i. (p < 0.05 and p < 0.01, 
respectively; Fig. 4f ). Hence, C. jejuni induced increases in 
large intestinal pro-inflammatory cytokines were higher 
in  Nod2−/− as compared to WT mice.
Colonic cytokines of the IL‑23/IL‑22/IL‑18 axis in C. jejuni 
infected secondary abiotic  Nod2−/− mice
Recently our group showed that cytokines belonging to the 
IL-23/IL-22/IL-18 axis are involved in mediating murine 
C. jejuni infection [25, 30–32]. We therefore determined 
expression levels of respective cytokines upon C. jejuni 
infection of secondary abiotic  Nod2−/− mice. Whereas 
colonic IL-23p19 mRNA levels were comparable in naive 
and C. jejuni infected mice of either genotype (n.s.; Fig. 5a), 
IL-22 was up-regulated in the large intestines of both 
 Nod2−/− and WT mice at day 7 p.i. (p  <  0.001; Fig.  5b). 
Moreover, C. jejuni infection resulted in down-regulation 
of colonic IL-18 mRNA in  Nod2−/− mice only (p < 0.01; 
Fig.  5c). Whereas colonic IL-23p19 and IL-18 mRNA 
levels were lower in C. jejuni infected  Nod2−/− mice as 
compared to WT counterparts (p  <  0.005 and p  <  0.05, 
respectively; Fig. 5a, c), IL-22 expression was higher in the 
large intestines of  Nod2−/− versus WT mice at day 7 p.i. 
(p < 0.005; Fig. 5b). Hence, cytokines of the IL-23/IL-22/
IL-18 axis are differentially expressed upon C. jejuni infec-
tion of secondary abiotic  Nod2−/− mice.
Fig. 4 Colonic secretion of pro- and anti-inflammatory cytokines in C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype 
(WT; white circles) and  Nod2−/− mice (black circles) were generated by broad-spectrum antibiotic treatment and perorally infected with C. jejuni 
strain 81-176 by gavage at day (d) 0 and d1. a Nitric oxide, b TNF, c IFN-γ, d MCP-1, e IL-6 and f IL-10 concentrations were determined in superna-
tants of colonic ex vivo biopsies at day 7 postinfection. Naive (N) secondary abiotic mice served as uninfected controls. Medians (black bars), level of 
significance (p-value) determined by Mann–Whitney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from 
four independent experiments
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Ileal cytokine secretion in C. jejuni infected secondary 
abiotic  Nod2−/− mice
We next addressed whether C. jejuni induced cytokine 
secretion could also be observed in the small intesti-
nal tract. In fact, ileal TNF concentrations were higher 
in mice of either genotype at day 7 p.i. as compared to 
respective naive counterparts (p < 0.05; Fig. 6b), whereas 
TNF and nitric oxide levels were lower in both naive and 
C. jejuni infected  Nod2−/− as compared to WT controls 
(p  <  0.01–0.005; Fig.  6a, b). Furthermore, IFN-γ and 
IL-10 concentrations increased until 7 p.i. of WT, but 
not  Nod2−/− mice and were lower in the latter (p < 0.05 
and p < 0.001, respectively; Fig.  6c, f ). In addition, IL-6 
levels were lower in the ilea of  Nod2−/− as compared to 
WT mice at day 7 p.i. (p < 0.05; Fig. 6e). Hence, converse 
to the colon, ileal secretion of distinct cytokines was less 
pronounced in C. jejuni infected  Nod2−/− mice versus 
WT controls.
Pathogenic translocation in C. jejuni infected secondary 
abiotic  Nod2−/− mice
We next addressed whether viable C. jejuni could also be 
isolated from extra-intestinal compartments. Whereas 
C. jejuni was detectable in MLN of all  Nod2−/− and WT 
mice at day 7 p.i., the pathogen translocated to spleen and 
kidney of WT mice in 13.0 and 17.4% of cases, respec-
tively, but could not be cultured from respective organs 
of  Nod2−/− mice by direct plating (Fig. 7). Notably, irre-
spective of the genotype of mice, livers were free of viable 
C. jejuni (Fig. 7).
Given that mucins constitute a pivotal part of the 
mucus layer warranting epithelial barrier integrity and 
hence preventing from bacterial translocation [33, 34], 
we next measured mucin-2 (MUC2) expression levels in 
colonic ex  vivo biopsies derived from C. jejuni infected 
secondary abiotic  Nod2−/− mice. MUC2 expression was 
down-regulated in the colon upon C. jejuni infection of 
 Nod2−/−, but not WT mice (p < 0.05; Fig. 8), and colonic 
MUC2 mRNA levels were lower in the former versus 
the latter at day 7 p.i. (p  <  0.005; Fig.  8). Hence, even 
though MUC2 was down-regulated in C. jejuni infected 
 Nod2−/− mice, this did not result in increased pathogenic 
translocation from the intestinal tract to extra-intestinal 
compartments.
Cytokine responses in mesenteric lymph nodes 
and spleens upon C. jejuni infection of secondary abiotic 
 Nod2−/− mice
We next measured cytokine secretion in intestinal drain-
ing and systemic lymphatic tissues (i.e. MLN and spleen, 
respectively) following C. jejuni infection of secondary 
abiotic mice lacking Nod2. Whereas IFN-γ levels were 
elevated in MLN of both  Nod2−/− and WT mice at day 7 
p.i. (p < 0.001; Fig. 9b), C. jejuni induced increases in TNF 
and IL-6 secretion could be observed in MLN of  Nod2−/− 
mice only (p < 0.05; Fig. 9a, e). At day 7 p.i., TNF, MCP-1 
and IL-6 levels were higher in MLN of  Nod2−/− as com-
pared to WT mice (p < 0.05; Fig. 9a, c, e). Notably, IL-10 
secretion was virtually unaffected by C. jejuni infection 
(n.s.; Fig. 9f ). Hence, distinct pro-inflammatory cytokine 
were higher in the intestines draining MLN of C. jejuni 
infected  Nod2−/− as compared to WT mice. In the sys-
temic lymphatic compartment, however, virtually no C. 
jejuni induced increases in splenic cytokine secretion 
Fig. 5 Colonic expression of cytokines belonging to the IL-23/IL-22/IL-18 axis in C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary 
abiotic wildtype (WT; white circles) and  Nod2−/− mice (black circles) were generated by broad-spectrum antibiotic treatment and perorally infected 
with C. jejuni strain 81-176 by gavage at day (d) 0 and d1. a IL-23p19, b IL-22 and c IL-18 mRNA levels were determined in colonic ex vivo biopsies 
at day 7 postinfection by Real Time PCR and expressed in Arbitrary Units (fold expression). Naive (N) secondary abiotic mice served as uninfected 
controls. Medians (black bars), level of significance (p-value) determined by Mann–Whitney U test and numbers of analyzed animals (in parentheses) 
are indicated. Data were pooled from four independent experiments
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could be detected (Additional file  8: Figure S8). Nota-
bly, basal IL-6 levels were higher in spleens of secondary 
abiotic  Nod2−/− mice than WT controls (p < 0.05; Addi-
tional file 8: Figure S8E).
Discussion
In order to prevent the host from invading pathogens 
including C. jejuni and to successfully combat infec-
tion, a concerted action of pattern recognition recep-
tors, distinct innate and adaptive immune cells, and 
evolving signaling pathways are crucial [8–10]. In the 
present study we shed further light onto the role of the 
bacterial MDP sensor Nod2 in C. jejuni infection of sec-
ondary abiotic mice. Notably, Nod2 deficiency did not 
impact gastrointestinal colonization properties of C. 
jejuni, given that both secondary abiotic  Nod2−/− and 
WT mice harbored the pathogen with similar counts of 
up to  109 CFU per g colonic luminal content. This might 
appear somewhat surprising, given that Nod2 deficiency 
has been shown to be associated with altered expression 
of antimicrobial peptides such as defensins leading to an 
insufficient clearance of the pathogen [20, 35]. Despite 
the high pathogenic burden within the intestines, mice 
were macroscopically uncompromised and did not dis-
play overt clinical signs of campylobacteriosis such as 
wasting or bloody diarrhea. This is well in line with our 
previous infection studies in secondary abiotic mice that 
were deficient in matrix metalloproteinase (MMP) -2 or 
-9 [24, 36], in cytokines belonging to the IL-23/IL-22/
IL-18 axis [32] or in innate immune receptors includ-
ing Toll-like receptor (TLR) -4 or -9 and respective WT 
counterparts [8, 32]. Nevertheless, in our present and 
previous studies [8, 24, 32, 36], distinct C. jejuni induced 
microscopic changes within the intestinal tract such as 
Fig. 6 Ileal secretion of pro- and anti-inflammatory cytokines in C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT; 
white circles) and  Nod2−/− mice (black circles) were generated by broad-spectrum antibiotic treatment and perorally infected with C. jejuni strain 
81-176 by gavage at day (d) 0 and d1. a Nitric oxide, b TNF, c IFN-γ, d MCP-1, e IL-6 and f IL-10 concentrations were determined in supernatants of 
ileal ex vivo biopsies at day 7 postinfection. Naive (N) secondary abiotic mice served as uninfected controls. Medians (black bars), level of signifi-
cance (p-value) determined by Mann–Whitney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four 
independent experiments
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accelerated colonic epithelial apoptosis and pronounced 
influx of immune cells to the site of infection could be 
observed. Whereas Nod2 deficiency had no impact on 
C. jejuni induced colonic histopathological changes and 
apoptosis development, infected  Nod2−/− mice exhib-
ited more distinct regenerative properties counteracting 
potential cell damage than WT controls. Furthermore, 
adaptive immune cell populations such as T and B lym-
phocytes were less distinctly abundant in the large intes-
tines of C. jejuni infected  Nod2−/− as compared to WT 
mice, which is in line with our very recent investigations 
in conventionally colonized  Nod2−/− [37] and  Nod2−/− 
mice lacking IL-10 [38]. Our present colonic immune 
cell data are contrasted by the observed large intestinal 
secretion of pro-inflammatory mediators, given that C. 
jejuni induced increases in nitric oxide, TNF and IFN-γ 
protein concentrations were even more pronounced in 
 Nod2−/− mice which also held true for increased colonic 
TNF expression in C. jejuni infected conventionally colo-
nized  Nod2−/− versus to WT mice as shown previously 
[37]. Overall, standard deviations in pro-inflammatory 
cytokine concentrations were relative high in C. jejuni 
infected mice of either genotype. It is therefore tempting 
to speculate that the extent of against C. jejuni directed 
immune responses might differ individually in both 
 Nod2−/− and WT mice.
We have recently highlighted the importance of the 
IL-23/IL-22/IL-18 axis in murine C. jejuni infection [25, 
30–32]. In the present study we could demonstrate that 
respective cytokines were differentially expressed upon 
C. jejuni infection of secondary abiotic  Nod2−/− mice. 
As for large intestinal pro-inflammatory cytokines, C. 
jejuni induced up-regulation of colonic IL-22 mRNA was 
more pronounced in  Nod2−/− as compared to WT mice, 
whereas conversely, IL-18 was down-regulated in the for-
mer, and both IL-23p19 and IL-18 mRNA were lower in 
infected  Nod2−/− versus WT mice. IL-22 is a member of 
the IL-10 cytokine family and exerts dichotomous func-
tion which depends on the respective compartment and 
the surrounding cytokine milieu [31, 39, 40]. Whereas 
IL-22 exerts anti-inflammatory properties in the large 
intestinal tract [40], it has pro-inflammatory functions 
in the small intestines [29, 41, 42]. Given that IL-22 has 
been proven effective in antimicrobial host defence 
against C. jejuni [31, 32], more pronounced increases 
in IL-22 mRNA levels observed in C. jejuni infected 
 Nod2−/− mice might therefore point towards more dis-
tinct anti-pathogenic and anti-inflammatory counter-
regulatory measures within the well-orchestrated host 
immune responses upon C. jejuni infection. Opposed to 
IL-22, IL-23p19, the master regulator of IL-22 expression 
[43], as well as IL-18 that is known to amplify IL-22 pro-
duction during intestinal inflammation [41] were lower 
Fig. 7 Pathogenic translocation in C. jejuni infected secondary abiotic 
 Nod2−/− mice. Secondary abiotic wildtype (WT; white circles) and 
 Nod2−/− mice (black circles) were generated by broad-spectrum anti-
biotic treatment and perorally infected with C. jejuni strain 81-176 by 
gavage at day (d) 0 and d1. Translocating pathogens were assessed in 
ex vivo biopsies derived from mesenteric lymph nodes (MLN), spleen, 
liver and kidney at day 7 postinfection by culture. Medians (black bars) 
and numbers of mice harboring C. jejuni out of the total number of 
analyzed animals (in parentheses) are indicated. Data were pooled 
from four independent experiments
Fig. 8 Colonic mucin-2 expression in C. jejuni infected secondary 
abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT; white circles) 
and  Nod2−/− mice (black circles) were generated by broad-spectrum 
antibiotic treatment and perorally infected with C. jejuni strain 81-176 
by gavage at day (d) 0 and d1. Mucin-2 (MUC2) mRNA levels were 
determined in colonic ex vivo biopsies at day 7 postinfection by Real 
Time PCR and expressed in Arbitrary Units (fold expression). Naive (N) 
secondary abiotic mice served as uninfected controls. Medians (black 
bars), level of significance (p-value) determined by Mann–Whitney U 
test and numbers of analyzed animals (in parentheses) are indicated. 
Data were pooled from four independent experiments
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in C. jejuni infected  Nod2−/− as compared to WT mice. 
This might be due to a potential negative feed-back loop 
regulation between respective cytokines.
Even though the large intestinal tract constitutes the 
major predilection site of C. jejuni infection [8, 23, 44, 
45], we here additionally assessed pro-inflammatory 
cytokine secretion in the small intestine. Remarkably, 
as opposed to the colon, ileal nitric oxide, TNF, IFN-γ 
and IL-6 concentrations were lower in C. jejuni infected 
 Nod2−/− as compared to WT mice. It is hence tempting 
to speculate that Nod2 might have dichotomous func-
tions depending on the respective intestinal tissue, its 
immunological prerequisites, surrounding cytokines and 
other intestinal luminal factors.
To date, data are rather conflicting regarding the role 
of Nod2 in intestinal inflammation including C. jejuni 
infection. Depending on the applied in  vivo model 
Nod2 might either prevent from or even enhance colitis 
development in C. jejuni infected mice. For instance, in 
IL-10−/− mice that had been pre-treated with antibiotics 
for 1 week, Nod2 was shown to be essential for control-
ling campylobacteriosis, given that  Nod2−/− IL-10−/− 
mice exhibited an exacerbation of C. jejuni induced large 
intestinal inflammation [46]. In another study by Jamontt 
and colleagues [47], however, Nod2 was shown to pro-
mote IL-10−/− colitis, given that  Nod2−/− IL-10−/− mice 
were protected from colitis development.
Also in non-infection induced intestinal inflamma-
tion models data regarding the impact of Nod in disease 
development are inconclusive so far. Following adaptive 
transfer of  Nod2−/− T lymphocytes, immunodeficient 
mice developed less severe chronic colitis, for instance, 
pointing towards a rather disease-promoting feature of 
Nod2 signaling [12]. Conversely, MDP application could 
sufficiently prevent from 2,4,6-trinitro-benzene-sulfonic 
acid (TNBS) induced colitis, whereas MDP-mediated 
Fig. 9 Secretion of pro- and anti-inflammatory cytokines in mesenteric lymph nodes of C. jejuni infected secondary abiotic  Nod2−/− mice. Second-
ary abiotic wildtype (WT; white circles) and  Nod2−/− mice (black circles) were generated by broad-spectrum antibiotic treatment and perorally 
infected with C. jejuni strain 81-176 by gavage at day (d) 0 and d1. a TNF, b IFN-γ, c MCP-1, d IL-12p70, e IL-6 and f IL-10 concentrations were deter-
mined in supernatants of ex vivo biopsies derived from mesenteric lymph nodes (MLN) at day 7 postinfection. Naive (N) secondary abiotic mice 
served as uninfected controls. Medians (black bars), level of significance (p-value) determined by Mann–Whitney U test and numbers of analyzed 
animals (in parentheses) are indicated. Data were pooled from three independent experiments
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prevention of diseases was overruled in  Nod2−/− mice 
indicative for a protective role of Nod2 signaling [48]. 
In an own study we further demonstrated that Nod2 is 
involved in protection of mice from Toxoplasma gondii 
induced acute ileitis [49].
Epithelial barrier integrity is pivotal for prevent-
ing pathogenic translocation from the intestinal tract 
to extra-intestinal including systemic tissue sites with 
potentially fatal consequences [50]. Even though the 
mucin MUC2 was down-regulated in C. jejuni infected 
 Nod2−/− mice, this did not result in increased pathogenic 
translocation rates to liver, kidney or spleen, whereas 
viable C. jejuni could be isolated in comparable numbers 
from MLN of all infected  Nod2−/− and WT mice. Inter-
estingly, secretion of pro-inflammatory cytokine includ-
ing TNF, MCP-1 and IL-6 were higher in MLN of C. 
jejuni infected  Nod2−/− as compared to WT mice. In the 
systemic lymphatic compartment, however, virtually no 
C. jejuni induced increases in cytokine secretion could be 
detected.
In conclusion, upon C. jejuni infection of secondary abi-
otic mice Nod2 signaling is involved in the initiation of a 
well-orchestrated innate and adaptive immune response 
but does not limit pathogen colonization. Future stud-
ies need to dissect the exact regulatory interactions to 
improve our understanding of the molecular mechanisms 
underlying campylobacteriosis.
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Additional files
Additional file 1: Figure S1. Fecal blood in C. jejuni infected secondary 
abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT; white circles) 
and  Nod2−/− mice (black circles) were generated by broad-spectrum 
antibiotic treatment and perorally infected with C. jejuni strain 81-176 by 
gavage at day (d) 0 and d1. Microscopic or macroscopic occurrence of 
blood in fecal samples before and after infection was assessed applying a 
standardized haemoccult scoring system (see methods). Absolute num-
bers of animals with blood-positive fecal samples out of the total number 
of analyzed mice are indicated (in parentheses). Data were pooled from 
four independent experiments.
Additional file 2: Figure S2. Colonic histopathological changes in 
C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary abiotic 
wildtype (WT, upper panel) and  Nod2−/− mice (lower panel) were gener-
ated by broad-spectrum antibiotic treatment and perorally infected with 
C. jejuni strain 81-176 by gavage at day (d) 0 and d1. Photomicrographs 
representative for four independent experiments (x100 magnification, 
scale bar 100 μm) depict histopathological mucosal changes in H&E 
stained large intestinal paraffin sections at day 7 following C. jejuni infec-
tion (d7, right panel). Naive secondary abiotic mice (left panel) served as 
uninfected controls.
Additional file 3: Figure S3. Colonic epithelial apoptosis in C. jejuni 
infected secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype 
(WT, upper panel) and  Nod2−/− mice (lower panel) were generated by 
broad-spectrum antibiotic treatment and perorally infected with C. jejuni 
strain 81-176 by gavage at day (d) 0 and d1. Photomicrographs represent-
ative for four independent experiments (x400 magnification, scale bar 20 
μm) depict apoptotic (caspase3 positive) cells (arrows) in large intestinal 
epithelia at day 7 following C. jejuni infection (d7, right panel) applying in 
situ immunohistochemistry of colonic paraffin sections. Naive secondary 
abiotic mice (left panel) served as uninfected controls.
Additional file 4: Figure S4. Proliferating colonic epithelial cells in 
C. jejuni infected secondary abiotic  Nod2−/− mice. Secondary abiotic 
wildtype (WT, upper panel) and  Nod2−/− mice (lower panel) were gener-
ated by broad-spectrum antibiotic treatment and perorally infected with 
C. jejuni strain 81-176 by gavage at day (d) 0 and d1. Photomicrographs 
representative for four independent experiments (x100 magnification, 
scale bar 100 μm) depict apoptotic (Ki67 positive) cells in large intestinal 
epithelia at day 7 following C. jejuni infection (d7, right panel) applying in 
situ immunohistochemistry of colonic paraffin sections. Naive secondary 
abiotic mice (left panel) served as uninfected controls.
Additional file 5: Figure S5. Colonic T lymphocytes in C. jejuni infected 
secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT, upper 
panel) and  Nod2−/− mice (lower panel) were generated by broad-
spectrum antibiotic treatment and perorally infected with C. jejuni strain 
81-176 by gavage at day (d) 0 and d1. Photomicrographs representative 
for four independent experiments (x400 magnification, scale bar 20 μm) 
depict colonic CD3 positive T lymphocytes at day 7 following C. jejuni 
infection (d7, right panel) applying in situ immunohistochemistry of 
colonic paraffin sections. Naive secondary abiotic mice (left panel) served 
as uninfected controls.
Additional file 6: Figure S6. Colonic regulatory T cells in C. jejuni 
infected secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype 
(WT, upper panel) and  Nod2−/− mice (lower panel) were generated by 
broad-spectrum antibiotic treatment and perorally infected with C. jejuni 
strain 81-176 by gavage at day (d) 0 and d1. Photomicrographs repre-
sentative for four independent experiments (x400 magnification, scale bar 
20 μm) depict colonic FOXP3 positive regulatory T cells at day 7 following 
C. jejuni infection (d7, right panel) applying in situ immunohistochemistry 
of colonic paraffin sections. Naive secondary abiotic mice (left panel) 
served as uninfected controls.
Additional file 7: Figure S7. Colonic B lymphocytes in C. jejuni infected 
secondary abiotic  Nod2−/− mice. Secondary abiotic wildtype (WT, upper 
panel) and  Nod2−/− mice (lower panel) were generated by broad-
spectrum antibiotic treatment and perorally infected with C. jejuni strain 
81-176 by gavage at day (d) 0 and d1. Photomicrographs representative 
for four independent experiments (x400 magnification, scale bar 20 μm) 
depict colonic B220 positive B lymphocytes at day 7 following C. jejuni 
infection (d7, right panel) applying in situ immunohistochemistry of 
colonic paraffin sections. Naive secondary abiotic mice (left panel) served 
as uninfected controls.
Additional file 8: Figure S8. Secretion of pro- and anti-inflammatory 
cytokines in spleens of C. jejuni infected secondary abiotic  Nod2−/− mice. 
Secondary abiotic wildtype (WT; white circles) and  Nod2−/−- mice (black 
circles) were generated by broad-spectrum antibiotic treatment and pero-
rally infected with C. jejuni strain 81-176 by gavage at day (d) 0 and d1. (A) 
Nitric oxide, (B) TNF, (C) IFN-γ, (D) MCP-1, (E) IL-6 and (F) IL-10 concentra-
tions were determined in supernatants of ex vivo biopsies derived from 
spleens at day 7 postinfection. Naive (N) secondary abiotic mice served 
as uninfected controls. Medians (black bars), level of significance (p-value) 
determined by Mann-Whitney U test and numbers of analyzed animals 
(in parentheses) are indicated. Data were pooled from four independent 
experiments.
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